Researchers uncover new therapeutic vulnerability in endocrine therapy-resistant breast cancers

Cloud technology with futuristic hologram on smartwatch

For patients with estrogen receptor (ER)-positive breast cancer, development of the so-called Y537S mutation signals that their disease has taken an aggressive course and may become resistant to endocrine therapy.

5 of the best YouTube channels to learn about Native culture

Previous article

New approach for delivering medication across the blood-brain barrier to treat brain tumors

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News